According to QY Research Medical, the cord blood banking services market size was valued at US$ 1.3 billion in 2020, and is projected to reach US$ 4.5 billion by 2030, growing at a CAGR of 13.6% from 2021 to 2030.
According to QY Research Medical, the cord blood banking services market size was valued at US$ 1.3 billion in 2020, and is projected to reach US$ 4.5 billion by 2030, growing at a CAGR of 13.6% from 2021 to 2030.
Cord blood contains a rich source of stem cells, which can treat more than 80 genetic diseases. Cord blood stem cells can treat chronic diseases such as cancer, diabetes, blood diseases, and immune diseases. Although, only a small amount of cord blood can be collected from a single umbilical cord, it contains large number of stem cells and is the only type of stem cell stored for future use. These cells are collected from hospitals & nursing homes and stored in cord blood banks for future use and can be stored for an average of 20-25 years. Government authorities have supported research and clinical trials of cord blood stem cells, thus increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies. The cord blood banking services market forecast from 2020 to 2030.
Full Report is ready | Request Sample of This Report @ https://qyresearchmedical.com/sample/112619
Market for cord blood banking services has increased since the last 20 years. At present, the market competition has increased while the companies are trying to increase the awareness related to the benefits of cord blood storage. Moreover, Cord Blood Registry and The Institute for Transfusion Medicine collaborated to launch a multi-year initiative to increase awareness about cord blood cells. With the help of campaigns, expectant parents are educated and guided about options available for cord blood banking related to the different financial schemes for storage and donation, which is expected to boost the cord blood banking services market growth. Major players such as Covis Group S.a.r.l, Americold Registry LLC and others have adopted the product acquisition to improve their product portfolio to maintain competition in the market. For instance, in November 2020, Covis completed the acquisition of Amag Pharmaceuticals, Inc. and this acquisition aims to improve the therapeutic portfolio and enhance the capabilities & offerings. Such instances are expected to provide lucrative cord blood banking services market opportunity.
The COVID-19 pandemic forced many companies in the global cord blood banking services market size to halt business operations for a short term to comply with new government regulations to curb the spread of the disease. This halt in operations directly impacted revenue flow of the global cord blood banking services market. In addition, there is a halt in manufacturing of industrial products, owing to lack of raw materials and manpower during the lockdown period. Further, no new consignments are received by companies that operate in this sector. Hence, halt in industrial activities and lockdowns for several months have affected the global cord blood banking services industry due to which the market witnessed a slow recovery during the forecast period.
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112619/2900
The cord blood banking services market size is segmented into storage services, component, application, and region. By storage services, it is classified into public cord blood banks and private cord blood banks. Private cord blood banks segment having the highest cord blood banking services market share.
By component, the market is segmented into cord blood and cord tissue. Cord tissue segment generated the highest revenue in 2020. By application, diabetes segment have the highest cord blood banking services market share. On the basis of region, the cord blood banking services market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to have the highest cord blood banking services market share, followed by Europe. LAMEA is predicted to grow faster than Asia-Pacific with a CAGR of 13.5% during the forecast period.
Competition Analysis
The key players that operate in this market include Americord Registry LLC, China Cord Blood Corporation, Covis Group, Cordlife Group Limited, Cryo-Cell International, Inc., Cord for Life, National Cord Blood Program, Cordvida, Perkinelmer Inc., and Lifecell international Pvt. Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cord blood banking services market analysis from 2020 to 2030 to identify the cord blood banking services industry opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cord blood banking services market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the cord blood banking services industry.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cord blood banking services market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
- BY STORAGE SERVICES
- Public Cord Blood Banks
- Private Cord Blood Banks
- BY COMPONENT
- Cord Blood
- Cord Tissue
- BY APPLICATION
- Cancer Disease
- DIabetes
- Blood Disease
- Immune Disorders
- Metabolic Disorders
- Others
- BY REGION
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- Italy
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Latin America
- Middle East
- Africa
- North America
Key Market Players
- AMAG Pharmaceuticals, Inc.
- Americord Registry LLC
- China Cord Blood Corporation
- Cord Blood America
- Cordlife Group LImited
- cordvida
- Cryo-cell International
- Cryoholdco DE LatinoAMerica
- Esperite N.V.
- LifeforceCryobank Science Inc
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112619/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/